BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33098266)

  • 21. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway.
    Chen G; Sun W; Hua X; Zeng W; Yang L
    Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [H3K27 acetylation promotes lncRNA OIP5-AS1 transcription and induces apoptosis of nasal epithelial cells in allergic rhinitis through up-regulation of TLR4].
    Xie Y; She Z; Li R; Wu R; Wang R; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):419-427. PubMed ID: 38790098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly-expressed lncRNA FOXD2-AS1 in adipose mesenchymal stem cell derived exosomes affects HaCaT cells via regulating miR-185-5p/ROCK2 axis.
    Chang H; Chen J; Ding K; Cheng T; Tang S
    Adipocyte; 2023 Dec; 12(1):2173513. PubMed ID: 36775902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143.
    An Q; Zhou L; Xu N
    Biomed Pharmacother; 2018 Jul; 103():415-420. PubMed ID: 29674277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer.
    Ma HW; Xi DY; Ma JZ; Guo M; Ma L; Ma DH; Li PW; Guo CA
    Dis Markers; 2020; 2020():8140989. PubMed ID: 32051698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA FOXD2-AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR-206/MAP3K1 axis.
    Hu W; Feng H; Xu X; Huang X; Huang X; Chen W; Hao L; Xia W
    Cancer Med; 2020 Aug; 9(15):5620-5631. PubMed ID: 32558350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
    Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
    Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA FOXD2-AS1 Promotes Pancreas Adenocarcinoma Cell Invasion and Migration by Sponging miR-30a-3p to Upregulate COX-2.
    Ye Z; Yang Y; Wei Y; Li L; Wang X; Zhang J
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):25-33. PubMed ID: 35377978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
    Hu MJ; Long M; Dai RJ
    Mol Cell Biochem; 2022 Jan; 477(1):191-203. PubMed ID: 34652536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [FOXD2-AS1 is corelated with clinicopathological parameter of laryngeal carcinoma and promote cancer cell proliferation].
    Chen W; Sun SG; Jiang MX; Li SS; Yuan K
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 33(5):436-440. PubMed ID: 31163553
    [No Abstract]   [Full Text] [Related]  

  • 39. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.
    Gao Y; Zou T; Liang W; Zhang Z; Qie M
    Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p.
    Zhao J; Zeng XB; Zhang HY; Xiang JW; Liu YS
    Open Med (Wars); 2020; 15(1):921-931. PubMed ID: 33336050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.